The latest closing stock price for Chemomab Therapeutics as of September 18, 2024 is 1.76.
An investor who bought $1,000 worth of Chemomab Therapeutics stock at the IPO in 2019 would have $-990 today, roughly -1 times their original investment - a -53.44% compound annual growth rate over 6 years.
The all-time high Chemomab Therapeutics stock closing price was 172.80 on February 12, 2019.
The Chemomab Therapeutics 52-week high stock price is 2.55, which is 44.9% above the current share price.
The Chemomab Therapeutics 52-week low stock price is 0.42, which is 76.1% below the current share price.
The average Chemomab Therapeutics stock price for the last 52 weeks is 0.87.
An investor who bought $1,000 worth of Chemomab Therapeutics stock at the IPO in 2019 would have $-990 today, roughly -1 times their original investment - a -53.44% compound annual growth rate over 6 years.
The all-time high Chemomab Therapeutics stock closing price was 172.80 on February 12, 2019.
The Chemomab Therapeutics 52-week high stock price is 2.55, which is 44.9% above the current share price.
The Chemomab Therapeutics 52-week low stock price is 0.42, which is 76.1% below the current share price.
The average Chemomab Therapeutics stock price for the last 52 weeks is 0.87.